Latham & Watkins Advises Ro in its Acquisition of Sperm Analysis and Storage Company Dadi

A corporate deal team advises the company offering a suite of at-home fertility services.

March 01, 2022

Ro, a direct-to-patient healthcare company, has announced the acquisition of Dadi, a fertility company specializing in the facilitation of sperm testing, analysis, and storage.

Latham & Watkins LLP represents Ro in the acquisition with a corporate deal team led by New York partner Peyton Worley and Los Angeles partner Brian Duff, with New York associate Eduard Grigoryan.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.